Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-09-02

Clinical Trial Update: Effectiveness and Safety of Topical Halobetasol Propionate in the Treatment of Patients With Psoriasis [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports on the effectiveness and safety of topical halobetasol propionate for psoriasis in Phase 2 and Phase 3 trials sponsored by Az…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HALOBETASOL PROPIONATE (Halobetasol propionate)

Snippet

Sponsor: Azidus Brasil | Conditions: Psoriasis | Phase 2, Phase 3 | Status: COMPLETED